Home » Topics » BioWorld Science

BioWorld Science
RSS

Orca opens phase Ib study of TregGraft in hematologic malignancies

Dec. 10, 2019

Sinovent studies small-molecule human URAT1 inhibitor XNW-3009 in phase I

Dec. 10, 2019

FDA removes clinical hold on Abeona's phase III VIITAL study of EB-101

Dec. 10, 2019

LAIMU synthesizes new compounds for allergy

Dec. 10, 2019

Gilead Sciences identifies new benzamides for liver diseases

Dec. 10, 2019

Nerviano Medical Sciences presents new IDH1 and/or IDH2 mutant inhibitors

Dec. 10, 2019

Indivior selects CRO to conduct phase I study of INDV-2000

Dec. 10, 2019

Guangzhou Henovcom Bioscience discloses ENPP2 inhibitors

Dec. 10, 2019

Vedanta initiates first-in-patient study of VE-800 with Opdivo in advanced or metastatic cancer

Dec. 10, 2019

AMR Centre patents new antibacterials

Dec. 10, 2019

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...